Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Effectiveness of Adalimumab (Humira) in Patients With Ankylosing Spondylitis in Clinical Routine
This study is currently recruiting participants.
Verified November 2011 by Abbott
Study NCT01079182   Information provided by Abbott

First Received on March 1, 2010.   Last Updated on December 29, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ankylosing Spondylitis
Additional conditions recognized in this trial
Spondylitis
Spondylitis, Ankylosing
More general conditions related to this trial
Ankylosis
Arthritis
Bone Diseases
Bone Diseases, Infectious
Infection
Joint Diseases
Musculoskeletal Diseases
Spinal Diseases
Spondylarthritis
Spondylarthropathies
Interventions listed in this trial
adalimumab (Humira)
Additional drug interventions recognized in this trial
Adalimumab
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antirheumatic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Abbott


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services